ARTICLE | Company News
Receptos rises on takeover speculation
June 11, 2015 1:21 AM UTC
Receptos Inc. (NASDAQ:RCPT) gained $20.08 (13%) to $180.52 after media reports said the autoimmune company rejected a buyout offer from AstraZeneca plc (LSE:AZN; NYSE:AZN) worth $200 per share. The offer would value Receptos at $6.3 billion.
Reports also said Receptos denied bids from Gilead Sciences Inc. (NASDAQ:GILD) and Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) worth up to $280 per share, which would value Receptos at $8.8 billion. ...